September 2016
Volume 57, Issue 12
ARVO Annual Meeting Abstract  |   September 2016
The Effect of BH4 Supplementation in Retinal Ischemia
Author Affiliations & Notes
  • Ciara Cunning
    Queen's University Belfast, Ballymena, United Kingdom
  • Kevin Edgar
    Queen's University Belfast, Ballymena, United Kingdom
  • Tom A Gardiner
    Queen's University Belfast, Ballymena, United Kingdom
  • Denise McDonald
    Queen's University Belfast, Ballymena, United Kingdom
  • Footnotes
    Commercial Relationships   Ciara Cunning, None; Kevin Edgar, None; Tom Gardiner, None; Denise McDonald, None
  • Footnotes
    Support  British Heart Foundation, DEL
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 2705. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ciara Cunning, Kevin Edgar, Tom A Gardiner, Denise McDonald; The Effect of BH4 Supplementation in Retinal Ischemia. Invest. Ophthalmol. Vis. Sci. 2016;57(12):2705.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Retinopathy of prematurity (ROP) is a serious sight-threatening complication of therapeutic hyperoxia caused by oxidative insult to the immature retinal blood vessels leading to tissue ischemia and hypoxia-induced neovascularisation. Previously we have shown that tissue hypoxia induces the production of the pro-inflammatory mediators TNFα and inducible nitric oxide synthase (iNOS). iNOS is dependent upon the co-factor tetrahydrobiopterin (BH4) absence of which leads to aberrant production of superoxide. As we have previously shown that BH4 is depleted by hyperoxia, we investigated the contribution of BH4 to inflammation-induced damage in the murine model of oxygen-induce retinopathy (OIR) using hph-1 mice that are deficient in GTPCH, the rate limiting enzyme for the production of BH4.

Methods : Wild type, hph-1 heterozygotic (hph-1+/-) and hph-1 homozygotic (hph-1-/-) mice were subjected to oxygen induced retinopathy (OIR) by exposure to hyperoxia from postnatal day (P) 7 to P12. On return to room air at P12, treatment was commenced with the BH4 precursor sepiapterin or vehicle control (VC) and retinal, lung and brain tissue was collected 48h later at P14. BH4 levels were determined by HPLC analysis, NOS activity by Activity Assay, apoptosis by TUNEL and superoxide by dihydroethidium (DHE) fluorescence. Gene expression was measured by qPCR. Retinal flat mounts were stained with lectin to visualise vascular area and microglial cell density.

Results : HPLC analysis confirmed a decrease in BH4 levels from WT, through hph-1+/- to hph-1-/-, which was elevated following sepiapterin supplementation. NOS activity was reflective of BH4 levels, decreasing across genotypes and enhanced in the presence of BH4. INOS gene expression was unaltered by supplementation. Notably, BH4 supplementation caused a significant decrease in hypoxia-induced TUNEL staining in the inner nuclear layer (INL) with decreases of 54% in WT, 31% in hph-1+/- and 20% in hph-1-/- animals. In addition, BH4 treated groups had significantly diminished superoxide formation with the WT, hph-1+/- and hph-1-/- groups showing decreases in DHE fluorescence of 41%, 40% and 44% respectively. This correlated with a trend towards increased vascular coverage.

Conclusions : Together our results demonstrate that BH4 supplementation exerts a neuro-protective effect during the ischaemic-hypoxic phase of OIR by modulating the cellular redox state.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.